Lumenis(R) Introduces AcuPulse(TM) for Fractional Laser ...(tients are offered significant wrinkle r...),Health

Date:10/1/2009

tients are offered significant wrinkle resolution with minimal downtime lasting only 4-7 days," said Dr. E. Victor Ross, Director of the Laser and Cosmetic Dermatology Center of Scripps Health in San Diego, California. "Based on the clinical treatments, we expect histology's to show that the AcuPulse(TM), with its SuperPulse(TM) mode, ablates tissue in a mode similar to that of the UltraPulse®, which has proven itself a contributor toward excellent patient outcomes. We are excited to see an industry leader listening to the market and making a quality product available to meet the needs of more physicians," said Dr. Girish Munavalli. Medical Director of the Dermatology, Laser, and Vein Specialists of the Carolinas in Charlotte, North Carolina.

About the AcuPulse(TM) CO2 Laser System

The AcuPulse(TM) Fractional CO2 Laser System is the only laser of its kind providing true SuperPulse(TM) technology, as well as Continuous Wave (CW) technology, combined with the benefits of the legendary scanning heritage within the Lumenis CO2 Product line. With the SuperPulse(TM) technology Lumenis provides another segment in their pulsed CO2 Fractional Laser Systems other than the UltraPulse®, already proven to be one of the most effective laser systems for fractional laser treatments of the skin. With less thermal damage per treatment spot than standard CW lasers, the AcuPulse(TM) with SuperPulse(TM) technology is poised to be a significant player in the mid-price point fractional laser system landscape, rounding off the Lumenis portfolio for this application. The scanning technology for the deep fractional application is a direct regeneration of Lumenis' legendary UltraPulse® DeepFX(TM) scanner, providing the same spot size and variability in the size, shape, and density of the patterns. In addition to these technology benefits the AcuPulse(TM) is designed with a state of the art touchscreen user interface and safety control systems t
'/>"/>

SOURCE Lumenis Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Senate Introduces Bill to Boost Participation in Clinical Trials for Rare Diseases
2. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
3. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
4. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
5. Siemens Introduces New Standard of Care for Breast Ultrasound
6. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
7. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
8. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
9. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
10. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
11. Dr. Dello Russo Introduces the New EYE-Q Lasik